Verrica Pharmaceuticals

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$5,023
$5,092
$14,344
$12,702
Gross Profit
4,134
3,691
13,235
12,208
EBITDA
-9,521
-6,570
2,004
2,534
EBIT
-9,715
-6,760
1,820
2,335
Net Income
-9,682
-8,074
-274
204
Net Change In Cash
5,023
5,092
14,344
12,702
Free Cash Flow
-9,163
-4,591
9,685
-10,044
Cash
20,600
30,147
21,097
15,396
Basic Shares
10,652
10,652
9,490
9,490

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$35,577
$7,566
$5,124
$9,032
Gross Profit
32,136
4,826
4,378
8,307
EBITDA
-9,363
-65,898
-62,197
-21,597
EBIT
-10,144
-67,167
-63,033
-22,315
Net Income
-17,886
-76,579
-66,995
-24,487
Net Change In Cash
35,577
7,566
5,124
9,032
Cost of Revenue
18,521
Free Cash Flow
-17,627
-60,954
-38,939
-18,952
Cash
30,147
46,329
69,547
34,273
Basic Shares
10,652
5,180
4,534
3,416

Earnings Calls

QuarterEPS
2026-03-31
-$0.45
2025-12-31
-$0.51
2025-09-30
$0.13
2025-06-30
$0.02